ArticleDiscover oncology2025
Metastatic neuroendocrine carcinoma in inguinal region complicated with membranous nephropathy: a case report.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neuroendocrine neoplasms (NENs) are rare, malignant tumors characterized by variable incidence rates globally, with an overall trend of increasing frequency. The gastrointestinal tract and lungs are the most common primary sites for NENs. Between 11% and 22% of NENs present without an identifiable primary site, with the liver being the most frequent site for metastases. However, metastasis to the inguinal lymph nodes remains uncommon. Tumor-associated kidney disease can occur in association with both solid tumors and hematologic malignancies. Membranous nephropathy is the most prevalent pathological type of tumor-associated kidney disease in patients with solid tumors, and its occurrence in patients with neuroendocrine carcinoma is extremely rare. This article discusses the case of a 72-year-old male patient with metastatic neuroendocrine carcinoma of unknown primary origin, presenting with inguinal metastasis and membranous nephropathy. It details the patient's clinical presentation, diagnostic process, treatment plan, and prognosis, with the goal of increasing awareness and understanding of this rare condition and reviewing pertinent literature.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.